<DOC>
	<DOC>NCT01371695</DOC>
	<brief_summary>The purpose of this study is to determine whether Insulin-like Growth Factor II is elevated sufficiently to detect Cervical Intraepithelial Neoplasia II (CIN II), Cervical Intraepithelial Neoplasia III (CIN III), and cervical cancer.</brief_summary>
	<brief_title>Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma in Situ</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Uterine Cervical Dysplasia</mesh_term>
	<criteria>Age 18 75 years Female Normal medical history Medical history of a single type of cancer confirmed by biopsy or equivalent criteria Squamous cell carcinoma of organs other than cervix Adenocarcinoma Medical history of inflammatory disease May be pregnant Pap smear positive for Cervical Intraepithelial Neoplasia II or III Squamous cell cervical cancer confirmed by biopsy Informed consent Willingness to submit a blood sample by venipuncture Willingness to submit a second blood sample if necessary Age &lt; 18 or &gt; 75 years Medical history of cancer other than cervical cancer, Nonisletcell tumor hypoglycemia, Growth hormone deficiency, Acromegaly, Hepatoma, inflammatory disease in addition to confirmed CIN and cervical cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>IGF-II levels</keyword>
</DOC>